{"id":"W150401912","doi":"10.3833/pdr.v2011i6.1485","title":"Boehringer Ingelheim Licenses Zealand Pharma’s Drug Candidates for Type 2 Diabetes and Obesity","year":2011,"lang":"en","type":"article","venue":"PharmaDeals Review","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Milestone; Type 2 diabetes; Payment; Obesity; Quarter (Canadian coin); Business; Diabetes mellitus; Internal medicine; Finance; Endocrinology; Geography","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581792,0.001540021,0.0009635446,0.001429958,0.0004931893,0.001082871,0.000734316,0.001917712,0.1334855],"category_scores_gemma":[0.002202543,0.0006473921,0.0007753851,0.0009025202,0.0006898682,0.001209942,0.0008683789,0.002272449,0.06861438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005524302,"about_ca_system_score_gemma":0.002675557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004254906,"about_ca_topic_score_gemma":0.006558937,"domain_scores_codex":[0.9992042,0.0001092574,0.00004960927,0.0001372257,0.0004027111,0.00009706282],"domain_scores_gemma":[0.9991739,0.0002290674,0.0000900053,0.00006821009,0.0002447188,0.0001939372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001295465,0.0002989865,0.0004804939,0.003519294,0.0001056793,0.001309269,0.0001783223,0.0002522063,0.07511213,0.01126578,0.2641882,0.6419942],"study_design_scores_gemma":[0.0006006438,0.0006570631,0.001560555,0.0005742679,0.00009260792,0.001508994,0.0000463114,0.0002577152,0.007291645,0.001214279,0.9861712,0.00002478072],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01510758,0.2437104,0.01829716,0.01572483,0.006165507,0.002422601,0.00841501,0.004159301,0.6859975],"genre_scores_gemma":[0.04371347,0.07704128,0.01714911,0.002613166,0.0007278643,0.001062857,0.006328654,0.0003896276,0.850974],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1334855,"threshold_uncertainty_score":0.4465535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08240199183654418,"score_gpt":0.3650932836274937,"score_spread":0.2826912917909495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}